Literature DB >> 12189005

The health effects of ecstasy: a literature review.

Linda R Gowing1, Susan M Henry-Edwards, Rodney J Irvine, Robert L Ali.   

Abstract

Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is the third most used illicit drug, after cannabis and amphetamines. There has been considerable interest in the adverse effects of use, with particular attention given to a small number of deaths related to ecstasy use, and the neurotoxic effects of MDMA. This paper reviews case reports of adverse effects attributed to ecstasy use, and the findings of animal and human studies, so as to identify the health effects of ecstasy use, and factors contributing to their occurrence. The incidence of serious acute adverse events related to ecstasy is low. It is the unpredictability of those adverse events and the risk of mortality and substantial morbidity that makes the health consequences of ecstasy significant. Hyperthermia and hyponatraemia are the most significant acute adverse effects, and can occur even when MDMA is the only drug used. Ecstasy users should be aware of the importance of controlling body temperature and fluid intake, early signs of adverse effects, and the need to seek medical assistance promptly. Neurotoxicity is potentially the most significant long-term effect of ecstasy. The clinical implications of neurotoxicity are uncertain at this time, but short-term memory impairment may be significant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189005     DOI: 10.1080/09595230220119363

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  25 in total

Review 1.  Synthetic cathinones ("bath salts").

Authors:  Matthew L Banks; Travis J Worst; Daniel E Rusyniak; Jon E Sprague
Journal:  J Emerg Med       Date:  2014-02-22       Impact factor: 1.484

2.  Disinhibiting neurons in the dorsomedial hypothalamus delays the onset of exertional fatigue and exhaustion in rats exercising in a warm environment.

Authors:  Dmitry V Zaretsky; Hannah Kline; Maria V Zaretskaia; Mary Beth Brown; Pamela J Durant; Nathan J Alves; Daniel E Rusyniak
Journal:  Brain Res       Date:  2018-03-22       Impact factor: 3.252

3.  Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study.

Authors:  Anja C Huizink; Robert F Ferdinand; Jan van der Ende; Frank C Verhulst
Journal:  BMJ       Date:  2006-02-24

4.  Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.

Authors:  Eugene A Kiyatkin; Suelynn Ren; Ken T Wakabayashi; Michael H Baumann; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

5.  Additive Effects of Former Methylenedioxymethamphetamine and Cannabis Use on Subclinical Psychotic Symptoms.

Authors:  Berker Duman; Nilay Sedes; Bora Baskak
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

6.  The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes.

Authors:  Emily Joy Jaehne; Abdallah Salem; Rodney James Irvine
Journal:  Psychopharmacology (Berl)       Date:  2008-08-06       Impact factor: 4.530

7.  Substance Use Disorders and Neurologic Illness.

Authors:  Robert D. Davies; Christian Thurstone; Kelly Woyewodzic
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

8.  Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and behavioral responses.

Authors:  Daniel E Rusyniak; Maria V Zaretskaia; Dmitry V Zaretsky; Joseph A DiMicco
Journal:  Brain Res       Date:  2008-06-14       Impact factor: 3.252

9.  Pharmacodynamic characterization of insulin on MDMA-induced thermogenesis.

Authors:  Matthew L Banks; Sarah K Buzard; Candice M Gehret; Alexa N Monroy; M Alexander Kenaston; Edward M Mills; Jon E Sprague
Journal:  Eur J Pharmacol       Date:  2009-05-29       Impact factor: 4.432

10.  Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia.

Authors:  Emily Joy Jaehne; Abdallah Salem; Rodney James Irvine
Journal:  Psychopharmacology (Berl)       Date:  2007-05-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.